ArticleFrontiers in nutrition2026
A multidimensional muscle-fat-metabolism model for severity stratification in COPD: a multi-center cross-sectional study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a systemic disorder characterized by significant body composition alterations, including muscle loss (sarcopenia) and abnormal fat distribution. These changes contribute to a high metabolic burden, with increased resting energy expenditure and systemic inflammation accelerating disease progression. Traditional assessments like body mass index (BMI) fail to capture these complex interactions. This study aimed to evaluate a multidimensional "muscle-fat-metabolism" framework for stratifying COPD risk and severity. Methods: In this multi-center, cross-sectional study, 377 participants (213 stable COPD patients, 164 healthy controls) underwent bioelectrical impedance analysis (BIA) to assess body composition parameters, including fat-free mass index (FFMI), appendicular skeletal muscle mass index (ASMI), visceral fat area (VFA), and basal metabolic rate (BMR) and other indicators. Spirometry was used to confirm COPD diagnosis and grade severity according to GOLD criteria. Statistical analyses included between-group comparisons, correlation analyses, and multivariate logistic regression to develop predictive models. Results: COPD patients exhibited significantly lower skeletal muscle mass (FFMI, ASMI) and higher systemic fat levels (FM, BFP) compared with controls. Logistic regression analysis suggested that FFMI and ASMI may be protective against COPD risk and severity, whereas FM and BFP may be risk factors for it. Appendicular and truncal fat decreased progressively with advancing GOLD stage. The integrated muscle-fat-metabolism model achieved excellent predictive performance for severe COPD. Body composition and metabolic markers substantially improved risk stratification in patients with COPD. Conclusion: An integrative assessment of muscle, fat, metabolic, inflammatory, and functional indicators provided a more effective tool for stratifying COPD risk and severity than conventional metrics. This framework facilitates early identification of high-risk phenotypes like sarcopenic obesity and supports the development of personalized management strategies for COPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.